Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Abfero Limited
Abfero Limited is a dissolved company incorporated on 14 March 2018 with the registered office located in Reading, Berkshire. Abfero Limited was registered 7 years ago.
Watch Company
Status
Dissolved
Dissolved on
6 May 2025
(6 months ago)
Was
7 years old
at the time of dissolution
Via
voluntary
strike-off
Company No
11255897
Private limited company
Age
7 years
Incorporated
14 March 2018
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Submitted
Dated
4 April 2024
(1 year 7 months ago)
Next confirmation dated
1 January 1970
No changes
occurred since incorporation
Accounts
Not Submitted
Awaiting first accounts
Learn more about Abfero Limited
Contact
Update Details
Address
The White Building 6th Floor
33 Kings Road
Reading
Berkshire
RG1 3AR
England
Address changed on
10 Dec 2021
(3 years ago)
Previous address was
Longwall Venture Partners, Quad One Becquerel Avenue Harwell Didcot Oxon OX11 0RA United Kingdom
Companies in RG1 3AR
Telephone
Unreported
Email
Unreported
Website
Abferopharmaceuticals.com
See All Contacts
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Robert Guglielmetti
Director • Executive Vice President • Danish • Lives in Denmark • Born in Apr 1964
Henrik Parker
Director • Executive Vice President • Danish • Lives in Denmark • Born in May 1978
Tobias Sidelmann Christensen
PSC • Danish • Lives in Denmark • Born in Jan 1984
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Pharmacosmos UK Limited
Henrik Parker is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2019–2024)
Period Ended
30 Apr 2024
For period
30 Apr
⟶
30 Apr 2024
Traded for
12 months
Cash in Bank
£9.22K
Decreased by £9.72K (-51%)
Turnover
Unreported
Same as previous period
Employees
2
Same as previous period
Total Assets
£9.22K
Decreased by £16.81K (-65%)
Total Liabilities
-£401.87K
Increased by £10K (+3%)
Net Assets
-£392.65K
Decreased by £26.81K (+7%)
Debt Ratio (%)
4359%
Increased by 2853.45% (+190%)
See 10 Year Full Financials
Latest Activity
Voluntarily Dissolution
6 Months Ago on 6 May 2025
Voluntary Gazette Notice
8 Months Ago on 18 Feb 2025
Application To Strike Off
9 Months Ago on 6 Feb 2025
Robert Guglielmetti Resigned
1 Year 2 Months Ago on 30 Aug 2024
Mr Henrik Parker Appointed
1 Year 2 Months Ago on 30 Aug 2024
Full Accounts Submitted
1 Year 2 Months Ago on 21 Aug 2024
Confirmation Submitted
1 Year 7 Months Ago on 17 Apr 2024
Abfero Pharmaceuticals, Inc (PSC) Resigned
1 Year 7 Months Ago on 16 Apr 2024
Tobias Sidelmann Christensen (PSC) Appointed
1 Year 7 Months Ago on 16 Apr 2024
Abridged Accounts Submitted
2 Years Ago on 2 Nov 2023
Get Alerts
Get Credit Report
Discover Abfero Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Final Gazette dissolved via voluntary strike-off
Submitted on 6 May 2025
First Gazette notice for voluntary strike-off
Submitted on 18 Feb 2025
Application to strike the company off the register
Submitted on 6 Feb 2025
Termination of appointment of Robert Guglielmetti as a director on 30 August 2024
Submitted on 6 Sep 2024
Appointment of Mr Henrik Parker as a director on 30 August 2024
Submitted on 5 Sep 2024
Total exemption full accounts made up to 30 April 2024
Submitted on 21 Aug 2024
Notification of Tobias Sidelmann Christensen as a person with significant control on 16 April 2024
Submitted on 17 Apr 2024
Cessation of Abfero Pharmaceuticals, Inc as a person with significant control on 16 April 2024
Submitted on 17 Apr 2024
Confirmation statement made on 4 April 2024 with no updates
Submitted on 17 Apr 2024
Unaudited abridged accounts made up to 30 April 2023
Submitted on 2 Nov 2023
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs